Get the Stockscreener App
14.02
0.18%
0.025
After Hours:
13.99
-0.025
-0.18%
Gh Research Plc stock is traded at $14.02, with a volume of 124.61K.
It is up +0.18% in the last 24 hours and up +9.84% over the past month.
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
See More
Previous Close:
$13.99
Open:
$14.02
24h Volume:
124.61K
Relative Volume:
0.40
Market Cap:
$729.17M
Revenue:
-
Net Income/Loss:
$-41.43M
P/E Ratio:
-17.74
EPS:
-0.79
Net Cash Flow:
$-39.97M
1W Performance:
+0.11%
1M Performance:
+9.84%
6M Performance:
+18.87%
1Y Performance:
+45.69%
1-Day Range:
$13.71
$14.31
1-Week Range:
$13.10
$15.01
52-Week Range:
$6.72
$20.50
Gh Research Plc Stock (GHRS) Company Profile
Compare GHRS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
14.02 | 867.79M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Jun-04-25 | Resumed | Cantor Fitzgerald | Overweight |
| Mar-13-25 | Initiated | Guggenheim | Buy |
| Mar-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Feb-13-25 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-16-22 | Initiated | H.C. Wainwright | Buy |
| Jun-16-22 | Initiated | ROTH Capital | Buy |
View All
Gh Research Plc Stock (GHRS) Latest News
Will GH Research PLC stock gain from strong economyQuarterly Profit Review & Community Driven Trade Alerts - newser.com
GH Research PLC Reports Q3 2025 Financial Results - TipRanks
Will GH Research PLC (1KA) stock benefit from sector leadership2025 Top Decliners & Smart Swing Trading Techniques - newser.com
Is GH Research PLC (1KA) stock attractive post correctionWeekly Stock Analysis & AI Based Buy/Sell Signal Reports - newser.com
Live market analysis of GH Research PLCJuly 2025 Big Picture & Risk Controlled Daily Plans - newser.com
Will GH Research PLC (1KA) stock rise with strong economy2025 Price Momentum & Fast Exit Strategy with Risk Control - newser.com
Is GH Research PLC stock dividend yield sustainableStop Loss & Accurate Trade Setup Notifications - newser.com
Understanding GH Research PLC’s price movementDip Buying & Long-Term Growth Stock Strategies - newser.com
Why GH Research PLC stock is favored by pension fundsTrade Analysis Summary & Verified Stock Trade Ideas - newser.com
Is GH Research PLC stock oversold or undervaluedPortfolio Update Summary & AI Forecasted Stock Moves - newser.com
GH Research PLC stock chart pattern explainedJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Historical volatility pattern of GH Research PLC visualized2025 Market Outlook & AI Forecasted Entry/Exit Points - newser.com
What’s next for GH Research PLC stock priceWeekly Profit Summary & Consistent Income Trade Ideas - newser.com
Discipline and Rules-Based Execution in GHRS Response - news.stocktradersdaily.com
Can GH Research PLC (1KA) stock deliver consistent EPS growthWeekly Profit Report & Proven Capital Preservation Methods - newser.com
Why millennials buy GH Research PLC (1KA) stockWeekly Trade Recap & Weekly Hot Stock Watchlists - newser.com
Gh Research Plc Stock (GHRS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.38%
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):